Your browser doesn't support javascript.
loading
Recent advance in the study of novel anti-tumor targets and drugs--aurora kinase and Pin1 / 药学学报
Acta Pharmaceutica Sinica ; (12): 264-269, 2009.
Article in Chinese | WPRIM | ID: wpr-278272
ABSTRACT
Malignant tumor, one of the most refractory diseases, plays a threaten role in human health, the therapy and research on malignant tumor have taken a long way to go. The anti-tumor drugs which are the essential therapy strategies upgrade with the development of new anti-tumor targets and the research on tumor pathogenesis. Aurora kinase and Pin1, the novel anti-tumor targets, maintain the important relationship with tumor. Many new compounds designed on these targets have excellent anti-tumor effects and also enter into phase I or phase II clinical trial.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Pathology / Pharmacology / Piperazines / Naphthoquinones / Protein Serine-Threonine Kinases / Apoptosis / Peptidylprolyl Isomerase / Aurora Kinases / NIMA-Interacting Peptidylprolyl Isomerase / Metabolism Limits: Humans Language: Chinese Journal: Acta Pharmaceutica Sinica Year: 2009 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pathology / Pharmacology / Piperazines / Naphthoquinones / Protein Serine-Threonine Kinases / Apoptosis / Peptidylprolyl Isomerase / Aurora Kinases / NIMA-Interacting Peptidylprolyl Isomerase / Metabolism Limits: Humans Language: Chinese Journal: Acta Pharmaceutica Sinica Year: 2009 Type: Article